0001593968-21-001515.txt : 20210603
0001593968-21-001515.hdr.sgml : 20210603
20210603161536
ACCESSION NUMBER: 0001593968-21-001515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WRIGHT LISA
CENTRAL INDEX KEY: 0001865017
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 21992662
MAIL ADDRESS:
STREET 1: C/O VERICEL CORPORATION
STREET 2: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-06-01
0000887359
Vericel Corp
VCEL
0001865017
WRIGHT LISA
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
false
false
Restricted Stock Unit
2021-06-01
4
A
false
1300
0
A
Common Stock
1300
1300
D
Stock Option (right to buy)
56.49
2021-06-01
4
A
false
3250
0
A
2031-06-01
Common Stock
3250
3250
D
Stock Option (right to buy)
56.49
2021-06-01
4
A
false
5877
0
A
2031-06-01
Common Stock
5877
5877
D
Restricted Stock Unit
2021-06-01
4
A
false
2351
0
A
Common Stock
2351
2351
D
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest in equal annual installments over three years, beginning on June 1, 2021.
No expiration date for this type of award.
These options, representing the right to purchase a total of 3,250 shares, shall vest and become exercisable in equal monthly installments over three years, beginning on June 1, 2021, contingent upon continued service to the Company.
These options, representing the right to purchase a total of 5,877 shares, shall vest and become exercisable in equal monthly installments beginning on June 1, 2021, and shall become fully vested and exercisable on the earlier of the date of the Company's next annual meeting of shareholders or April 27, 2022, contingent upon continued service to the Company.
These RSUs shall vest on the earlier of June 1, 2022 or the date of the Company's next annual meeting of shareholders, contingent upon continued service to the Company.
/s/ Sean Flynn, Attorney-in-Fact for Lisa Wright
2021-06-03
EX-24
2
powerofattorney-l_wright.txt
EX-24 DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 AND RULE 144 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes
and appoints each of Dominick C. Colangelo, Joseph Mara and Sean C. Flynn
as the undersigned's true and lawful attorney-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and
stead of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
(including any amendments thereto) with respect to the securities of
Vericel Corporation, a Michigan corporation (the "Company"), with the
United States Securities and Exchange Commission, any national securities
exchanges and the Company, as considered necessary or advisable under
Section 16(a) of the Securities Exchange Act of 1934 and the rules and
regulations promulgated thereunder, as amended from time to time (the
"Exchange Act");
(2) prepare, execute, acknowledge, deliver and file Forms 144 in
accordance with Rule 144 under the Securities Act of 1933 (the "Securities
Act"), and other documents in connection therewith as necessary or
desirable to be done under Rule 144;
(3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's
securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such
person to release any such information to the undersigned and approves and
ratifies any such release of information; and
(4) perform any and all other acts, which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the
undersigned in connection with the foregoing.
Additionally, the undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in his or her discretion on information provided to
such attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney will be in
such form and will contain such information and disclosure as such
attorney-in-fact, in his or her discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability
for the undersigned's responsibility to comply with the requirements of the
Exchange Act or the Securities Act, (ii) any liability of the undersigned
for any failure to comply with such requirements, or (iii) any obligation
or liability of the undersigned for profit disgorgement under Section 16(b)
of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Securities Act or the Exchange Act, including without limitation the
reporting requirements under Section 16 of the Exchange Act.
The undersigned hereby gives and grants the foregoing attorneys-in-fact
full power and authority to do and perform all and every act and thing
whatsoever requisite, necessary or appropriate to be done in and about the
foregoing matters as fully to all intents and purposes as the undersigned
might or could do if present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.
This Power of Attorney shall remain in full force and effect until
revoked by the undersigned in a signed writing delivered to such
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 26th day of May, 2021.
____/s/ Lisa
Wright_________________
Signature
Lisa
Wright_________________________
Print Name
Page 2 of 2